ZFP69B is a zinc finger transcription factor with dual roles in nuclear gene regulation and cellular homeostasis. As an RNA polymerase II-specific DNA-binding transcription factor, it localizes to the nucleus and nucleolus where it regulates transcriptional programs 1. ZFP69B is essential for Golgi structural integrity, maintaining organellar organization critical for cellular function. The gene functions as an oncogenic driver in multiple cancer types, with elevated expression correlating with poor prognosis in hepatocellular carcinoma and triple-negative breast cancer 23. Mechanistically, ZFP69B promotes cancer cell proliferation, migration, and invasion through m6A-regulated ferroptosis pathways, while also controlling cell adhesion and immune signaling programs via its transcriptional targets CLSPN and HNRNPR 21. Beyond oncology, ZFP69B-associated DNA methylation variants are linked to body composition and obesity in children, implicating epigenetic regulation of metabolic processes 4. In neurodegenerative disease, ZFP69B functions as a master transcriptional regulator in Parkinson's disease pathophysiology, suggesting broader roles in neuronal homeostasis 5. These findings establish ZFP69B as a promising therapeutic target across multiple disease contexts, warranting further mechanistic investigation.